Anthony Doyle, CFO: Biocryst Pharmaceuticals BCRX Buy · Filed 24/05/15

Trade details

Type: Insider buy
Amount: $202,191
Shares · price: 36,300 sh · $5.57 a share
Held after: 266,744 sh
Stock: Biocryst Pharmaceuticals BCRX
Person: Anthony DoyleCFO
Trade date: 24/05/14
Filed: 24/05/15
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 8 insiders
Holding change: +15.8%

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/04/14~24/06/13

Anthony Doyle's recent trades

No other trades yet.